These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 7943121)

  • 1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.
    Adamis AP; Miller JW; Bernal MT; D'Amico DJ; Folkman J; Yeo TK; Yeo KT
    Am J Ophthalmol; 1994 Oct; 118(4):445-50. PubMed ID: 7943121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
    Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
    Retina; 1999; 19(5):383-9. PubMed ID: 10546932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Funatsu H; Yamashita H; Nakanishi Y; Hori S
    Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation and inhibition of angiogenesis in diabetic retinopathy.
    Funatsu H; Yamashita H; Noma H; Shimizu E; Yamashita T; Hori S
    Jpn J Ophthalmol; 2001; 45(6):577-84. PubMed ID: 11754898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.
    Malecaze F; Clamens S; Simorre-Pinatel V; Mathis A; Chollet P; Favard C; Bayard F; Plouet J
    Arch Ophthalmol; 1994 Nov; 112(11):1476-82. PubMed ID: 7980139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Mitamura Y; Tashimo A; Nakamura Y; Tagawa H; Ohtsuka K; Mizue Y; Nishihira J
    Diabetes Care; 2002 Dec; 25(12):2352. PubMed ID: 12453985
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
    Funatsu H; Yamashita H; Noma H; Mochizuki H; Mimura T; Ikeda T; Hori S
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunodetection of vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy].
    Ozaki H; Hayashi H; Oshima K; Imanaga Y; Kuroki M; Arakawa F; Kuwahara M; Matsuoka Y
    Nippon Ganka Gakkai Zasshi; 1996 Mar; 100(3):208-12. PubMed ID: 8900585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
    Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
    Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Shimizu E; Hori S
    Am J Ophthalmol; 2003 Mar; 135(3):321-7. PubMed ID: 12614749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
    Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
    Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Lecube A; Segura RM; Sararols L; Simó R
    Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.